Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
4.56M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2.23M
-
Shares change
-
+226K
-
Total reported value, excl. options
-
$12.9M
-
Value change
-
+$1.31M
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$5.76
Significant Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) as of Q2 2025
25 filings reported holding TENX - TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q2 2025.
TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.23M shares
of 4.56M outstanding shares and own 48.9% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (378K shares), BVF INC/IL (340K shares), MILLENNIUM MANAGEMENT LLC (234K shares), Vivo Capital, LLC (208K shares), MORGAN STANLEY (178K shares), Integral Health Asset Management, LLC (167K shares), JANUS HENDERSON GROUP PLC (167K shares), ADAR1 Capital Management, LLC (156K shares), VR ADVISER, LLC (98.6K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (83.3K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.